Viewing nowCombinationPimace Tablet 60/5 milligrams
Fimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
Dongkook Pharmaceutical Co., Ltd.

MFDS item code 202300427 · Approved 2023.01.31 · Insurance code 653405310
Treatment of essential hypertension not controlled with fimasartan potassium monotherapy
This medication is used to effectively lower and improve blood pressure in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with pimasartan potassium.
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted with fimasartan before administering this drug; however, if blood pressure is not controlled as described below, switching directly to this drug may be considered. ㆍ 30/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams as monotherapy. ㆍ 60/5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy. Patients taking fimasartan and S-amlodipine (amlodipine) in combination may switch to this drug (a combination product with the same content of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary in elderly patients up to 70 years of age. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with 30 milligrams of fimasartan in this drug. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this drug should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy in pediatric and adolescent patients 18 years of age or younger have not been established.
This medicine can cause serious harm to the fetus and newborn if taken during pregnancy, especially during the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any of the ingredients in this medication, those who are pregnant or breastfeeding, patients undergoing kidney dialysis, patients with severe liver impairment, patients with biliary obstruction, and those with certain kidney disorders or diabetic nephropathy should not take this medication. Patients with low blood volume or salt, those with impaired kidney function, patients with renovascular hypertension, heart valve disease patients, severe hypotension patients, and the elderly should use this medication cautiously and observe their condition closely while on treatment. Side effects such as dizziness, headache, facial swelling, urinary problems, insomnia, and flushing may occur while taking this medication; any abnormal symptoms should be discussed with a physician. In cases of hypotension or electrolyte imbalance, especially at the beginning of treatment, symptoms of hypotension may appear, so patients should correct their condition before taking this medication and monitor it carefully while on treatment. This medication may increase blood potassium levels, so patients with heart failure or kidney problems should have regular blood tests. There may be interactions with other antihypertensives, certain diuretics, lithium, or non-steroidal anti-inflammatory drugs, so if you are taking any other medications, you must inform your healthcare provider. Pregnant or breastfeeding women should consult their specialist before taking this medication as it may pose risks to the fetus and newborn. Children under 18 years should avoid using this medication as its safety and efficacy have not been established. The elderly may also be more sensitive to this medication, so they should pay attention to dosage adjustments and potential side effects. Patients with moderate to severe liver impairment should not take this medication. In cases of overdose, hypotension, cardiac arrhythmias, or severe shock may occur, requiring immediate hospital treatment. This medication should be kept out of the reach of children and should not be transferred to other containers for safety.
Dizziness, orthostatic dizziness, headache, facial swelling, peripheral edema, urinary disorders, insomnia, flushing, fainting, sedation, migraine, dyspepsia, vomiting, nausea, upper abdominal pain, asthenia, foreign body sensation, elevated liver enzyme levels, decreased platelet count, increased serum creatine phosphokinase levels, cough, muscle contraction, musculoskeletal stiffness, itching, localized urticaria, facial flushing, erectile dysfunction, epilepsy, amyotrophic lateral sclerosis, neuropathy, neuronitis, facial paralysis, normal pressure hydrocephalus, spinal stenosis, acute pancreatitis, bowel obstruction, hemorrhagic duodenal ulcer, appendicitis, hemorrhoids, abdominal pain, intracranial hemorrhage, transient ischemic attack, atherosclerosis, worsening cerebral infarction, cerebral hemorrhage, liver cancer, colon carcinoma, neoplasm of unspecified nature, cervical cancer, prostate cancer, acute renal failure, chronic renal failure, kidney stones, pyelonephritis, urinary incontinence, rhinitis, pulmonary fibrosis, pharyngitis, pneumonia, lung disease, death, exacerbation of low back pain, osteoarthritis, arthropathy, hypoglycemia, hyperkalemia, pulmonary embolism, purpura, bradycardia, atrial fibrillation, coronary artery disease, aortic stenosis, heart failure, hypertension, acute hepatitis, benign pituitary neoplasm, otitis media, uterine prolapse, recurrent cancer, cerebral infarction, fracture, chest pain, weakness, fatigue, pain, weight gain, weight loss, hypotension, vasculitis, tension headache, sensory loss, paresthesia, peripheral neuropathy, taste disturbance, tremor, extrapyramidal disorder, gynecomastia, changes in bowel habits, dry mouth, gingival hypertrophy, pancreatitis, hair loss, hyperhidrosis, purpura, skin discoloration, urticaria, pruritus, angioedema, erythema multiforme, myocardial infarction, arrhythmia, chest pain, hypotension, sinoatrial block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, constipation, skin erythema, maculopapular rash, heaviness, feeling of heat, decreased glucose tolerance, weakness, fatigue, fever, neck pain, shoulder pain, muscle weakness, tendinitis, osteomyelitis, shoulder impingement syndrome, lateral epicondylitis, synovitis, sciatica, jaw pain, arthralgia, osteoporosis, myalgia, pharyngitis, upper respiratory tract infection, sputum, rhinitis, epistaxis, bronchitis, paresthesia, numbness, tremor, hypertonia, insomnia, depression, anxiety, memory impairment, loss of appetite, gastroesophageal reflux, gastritis, diarrhea, constipation, functional gastrointestinal disorder, gastroenteritis, frequent urination, dysuria, hyperlipidemia, dyslipidemia, hypoglycemia, tinnitus, hearing impairment, hearing loss, pelvic inflammatory disease, vaginitis, benign prostatic hyperplasia, scrotal pain, blood pressure variability, fatty liver.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that blocks light and at a temperature between 1 degree and 30 degrees Celsius. Storing it this way will help maintain its effectiveness and ensure safe use.
Orange round film-coated tablet
30 tablets per bottle, 300 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
Dongkook Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Allyco Pharmaceutical Co., Ltd.
S-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Hana Pharm Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Korea Hutech Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.